Anti-MMP9 Antibody (Andecaliximab)
Catalog No.
F1464
Anti-MMP9 Antibody (Andecaliximab)
Featured Products
Andecaliximab is a biopharmaceutical targeting matrix metalloproteinase 9 (Andecaliximab is a recombinant IgG4 monoclonal antibody against MMP9. Andecaliximab has shown anti-fibrotic efficacy in a mouse model of idiopathic pulmonary fibrosis. Andecaliximab can be used in the study of gastric adenocarcinoma and idiopathic pulmonary fibrosis (IPF).
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
1518996-49-0
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
AB0045, GS-5745
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P14780
Human
Unconjugated
Monoclonal
Protein A
IgG4
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human MMP9 His at 2 ug/mL can bind Anti-MMP9 Antibody (Andecaliximab)
MMP9
Please avoid freeze-thaw cycles.